Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica
Published: Dec 10, 2020 SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) approval to initiate a patient series in Costa Rica to study its Motiva Mia ® system for minimally invasive augmentation, which includes the Motiva Ergonomix2 Diamond ® breast implant, and has completed the procedure in the first 21 patients in the study. “Motiva Mia is...
Source: biospace.com